Shotaro Iwamoto

Shotaro Iwamoto


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2011 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
SIShotaro Iwamoto
Shotaro Iwamoto
TDTakao Deguchi
Takao Deguchi
HOHideaki Ohta
Hideaki Ohta
NKNobutaka Kiyokawa
Nobutaka Kiyokawa
MTMasahito Tsurusawa
Masahito Tsurusawa
YKYoshihiro Komada
Yoshihiro Komada

14 February 2013 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
NSNaoto Sakurai
Naoto Sakurai
SIShotaro Iwamoto
Shotaro Iwamoto
YMYoshihiro Miura
Yoshihiro Miura
TNTomoki Nakamura
Tomoki Nakamura
AMAkihiko Matsumine
Akihiko Matsumine
YKYoshihiro Komada
Yoshihiro Komada

4 February 2014 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
SIShotaro Iwamoto
Shotaro Iwamoto
TYTakahiro Yonekawa
Takahiro Yonekawa
EAEiichi Azuma
Eiichi Azuma
TFTakao Fujisawa
Takao Fujisawa
MNMizuho Nagao
Mizuho Nagao
YKYoshihiro Komada
Yoshihiro Komada

1 January 2001 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
EAEiichi Azuma
Eiichi Azuma
MHMassahiro Hirayama
Massahiro Hirayama
MBMotoki Bonno
Motoki Bonno
SIShotaro Iwamoto
Shotaro Iwamoto
TKTadashi Kumamoto
Tadashi Kumamoto
HKHitoshi Kamiya
Hitoshi Kamiya
Cord blood transplantation (CBT) has been increasingly used to treat patients with hematological diseases, but active immunizations for patients have not been described. Patients certainly need immunizations following CBT, since transplanted cord blood is naive. The authors previously reported successful hematopoietic reconstitution following cord blood transplantation from an HLA-matched sibling in a transfusion-dependent child with Diamond-Blackfan anemia. No graft-versus-host disease, either acute or chronic, has been observed so far. Here, the authors report that immunological recovery of the patient has been rapid shortly after CBT and immunization has been done successfully. Vaccines (diphtheria, pertussis, tetanus, rubella, measles, and BCG) were administered during 22-34 months post-transplant. Seroconversion to these vaccines was excellent without significant adverse effects. These results indicate that both toxoid and live vaccines have been safely administered in the patient who underwent related cord blood transplantation.

1 January 2017 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
NYNoriko Yodoya
Noriko Yodoya
SIShotaro Iwamoto
Shotaro Iwamoto
AMAkihiko Matsumine
Akihiko Matsumine
EAEiichi Azuma
Eiichi Azuma
HTHidemi Toyoda
Hidemi Toyoda
YKYoshihiro Komada
Yoshihiro Komada
Although prognosis in patients with localized osteosarcoma has been dramatically improved by the introduction of multiple chemotherapy agents known as combination chemotherapy, there is growing concern about the development of secondary malignant neoplasms. We report the case of a 13-year-old girl in whom the diagnosis of Ewing sarcoma of bone localized on the shaft of left femur was made 2 years after successful treatment without radiotherapy for osteosarcoma of right proximal femur. EWS-FLI1 fusion gene was detected by reverse transcriptase-polymerase chain reaction. To our knowledge, this is the first case with Ewing sarcoma of the bone as a secondary malignant neoplasm developed in osteosarcoma survivor. We collected 15 cases, included this case, with secondary Ewing sarcoma family of tumor by utilizing the PubMed search and might consider the causes of this secondary cancer.